239 related articles for article (PubMed ID: 21890814)
81. Calcium supplements and colorectal adenomas. Polyp Prevention Study Group.
Baron JA; Beach M; Mandel JS; van Stolk RU; Haile RW; Sandler RS; Rothstein R; Summers RW; Snover DC; Beck GJ; Frankl H; Pearson L; Bond JH; Greenberg ER
Ann N Y Acad Sci; 1999; 889():138-45. PubMed ID: 10668490
[TBL] [Abstract][Full Text] [Related]
82. Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial.
Ni M; Zhang Y; Sun Z; Zhou Q; Xiao J; Zhang B; Lin J; Gong B; Liu F; Meng F; Zheng G; Wang Y; Gu L; Li L; Shen W; Chen Y; Liu Y; Li L; Ling T; Cheng H
Phytomedicine; 2024 May; 127():155496. PubMed ID: 38471368
[TBL] [Abstract][Full Text] [Related]
83. Fruits, vegetables, and adenomatous polyps: the Minnesota Cancer Prevention Research Unit case-control study.
Smith-Warner SA; Elmer PJ; Fosdick L; Randall B; Bostick RM; Grandits G; Grambsch P; Louis TA; Wood JR; Potter JD
Am J Epidemiol; 2002 Jun; 155(12):1104-13. PubMed ID: 12048224
[TBL] [Abstract][Full Text] [Related]
84. Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention.
Thompson P; Roe DJ; Fales L; Buckmeier J; Wang F; Hamilton SR; Bhattacharyya A; Green S; Hsu CH; Chow HH; Ahnen DJ; Boland CR; Heigh RI; Fay DE; Martinez ME; Jacobs E; Ashbeck EL; Alberts DS; Lance P
Cancer Prev Res (Phila); 2012 Dec; 5(12):1381-93. PubMed ID: 23060037
[TBL] [Abstract][Full Text] [Related]
85. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. The Polyp Prevention Study Group.
van Stolk RU; Beck GJ; Baron JA; Haile R; Summers R
Gastroenterology; 1998 Jul; 115(1):13-8. PubMed ID: 9649453
[TBL] [Abstract][Full Text] [Related]
86. Traditional Chinese medicine (Xiaoai Jiedu Decoction) as an adjuvant treatment for prevention new colorectal adenomatous polyp occurrence in post-polypectomy: Study protocol for a randomized controlled trial.
Zhou Q; Chen YG; Xiao J; Chen TT; Liu JR; Zhou W; Li WZ; Wang Y; Zhang BP; Lin J; Meng FD; Gong B; Zheng GY; Han ST; Cheng HB
Medicine (Baltimore); 2019 Aug; 98(31):e16680. PubMed ID: 31374049
[TBL] [Abstract][Full Text] [Related]
87. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
Cook NR; Lee IM; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
JAMA; 2005 Jul; 294(1):47-55. PubMed ID: 15998890
[TBL] [Abstract][Full Text] [Related]
88. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
[TBL] [Abstract][Full Text] [Related]
89. Effect of Low-dose and Standard-dose Aspirin on PGE
Drew DA; Schuck MM; Magicheva-Gupta MV; Stewart KO; Gilpin KK; Miller P; Parziale MP; Pond EN; Takacsi-Nagy O; Zerjav DC; Chin SM; Mackinnon Krems J; Meixell D; Joshi AD; Ma W; Colizzo FP; Carolan PJ; Nishioka NS; Staller K; Richter JM; Khalili H; Gala MK; Garber JJ; Chung DC; Yarze JC; Zukerberg L; Petrucci G; Rocca B; Patrono C; Milne GL; Wang M; Chan AT
Cancer Prev Res (Phila); 2020 Oct; 13(10):877-888. PubMed ID: 32718943
[TBL] [Abstract][Full Text] [Related]
90. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
[TBL] [Abstract][Full Text] [Related]
91. Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.
Chu DZ; Chansky K; Alberts DS; Meyskens FL; Fenoglio-Preiser CM; Rivkin SE; Mills GM; Giguere JK; Goodman GE; Abbruzzese JL; Lippman SM
Ann Surg Oncol; 2003 Oct; 10(8):870-5. PubMed ID: 14527904
[TBL] [Abstract][Full Text] [Related]
92. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.
Burn J; Bishop DT; Chapman PD; Elliott F; Bertario L; Dunlop MG; Eccles D; Ellis A; Evans DG; Fodde R; Maher ER; Möslein G; Vasen HF; Coaker J; Phillips RK; Bülow S; Mathers JC;
Cancer Prev Res (Phila); 2011 May; 4(5):655-65. PubMed ID: 21543343
[TBL] [Abstract][Full Text] [Related]
93. Celecoxib use and circulating oxylipins in a colon polyp prevention trial.
Martinez JA; Yang J; Wertheim BC; Roe DJ; Schriewer A; Lance P; Alberts DS; Hammock BD; Thompson PA
PLoS One; 2018; 13(4):e0196398. PubMed ID: 29698447
[TBL] [Abstract][Full Text] [Related]
94. Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies.
Nucera E; Schiavino D; Milani A; Del Ninno M; Misuraca C; Buonomo A; D'Ambrosio C; Paludetti G; Patriarca G
Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S75-8. PubMed ID: 10992567
[No Abstract] [Full Text] [Related]
95. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
Passarelli MN; Barry EL; Zhang D; Gangar P; Rees JR; Bresalier RS; McKeown-Eyssen G; Karagas MR; Baron JA
Br J Dermatol; 2018 Aug; 179(2):337-344. PubMed ID: 29570772
[TBL] [Abstract][Full Text] [Related]
96. [Journal club].
Püllen R; Dovjak P
Z Gerontol Geriatr; 2012 Oct; 45(7):673-4. PubMed ID: 23052284
[No Abstract] [Full Text] [Related]
97. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk.
Barry EL; Fedirko V; Uppal K; Ma C; Liu K; Mott LA; Peacock JL; Passarelli MN; Baron JA; Jones DP
Cancer Prev Res (Phila); 2020 Oct; 13(10):863-876. PubMed ID: 32655007
[TBL] [Abstract][Full Text] [Related]
98. Oral aspirin for preventing colorectal adenoma recurrence: A systematic review and network meta-analysis of randomized controlled trials.
Hoang KD; Chen JH; Huang TW; Kang YN; Chen C
PLoS One; 2024; 19(3):e0279784. PubMed ID: 38483854
[TBL] [Abstract][Full Text] [Related]
99. Serum salicylate levels and risk of recurrent colorectal adenomas.
Shaukat A; Grau MV; Church TR; Baxter G; Barry EL; Summers R; Sandler RS; Baron JA
Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):679-82. PubMed ID: 21307305
[TBL] [Abstract][Full Text] [Related]
100. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group.
Greenberg ER; Baron JA; Freeman DH; Mandel JS; Haile R
J Natl Cancer Inst; 1993 Jun; 85(11):912-6. PubMed ID: 8492320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
